301 related articles for article (PubMed ID: 2691125)
1. New therapeutic prospects of renin-angiotensin system inhibition.
Corvol P
Clin Exp Hypertens A; 1989; 11 Suppl 2():463-70. PubMed ID: 2691125
[TBL] [Abstract][Full Text] [Related]
2. Various approaches to blockade of the renin-angiotensin system: persistent renin response.
Brunner HR; Nussberger J; Waeber B
J Hypertens Suppl; 1990 Dec; 8(7):S149-53. PubMed ID: 2095383
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of the renin-angiotensin system.
Brunner HR; Nussberger J; Waeber B
Arzneimittelforschung; 1993 Feb; 43(2A):274-8. PubMed ID: 8498978
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
5. Evolution of angiotensin-converting enzyme inhibitors.
Wyvratt MJ
Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
[TBL] [Abstract][Full Text] [Related]
6. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
Pichler M; Klein W; Huber K; Pachinger O
Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520
[TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin system and body function.
Reid IA
Arch Intern Med; 1985 Aug; 145(8):1475-9. PubMed ID: 2992406
[TBL] [Abstract][Full Text] [Related]
9. Chemistry of the inhibitors of the renin-angiotensin system.
Geiger R
Arzneimittelforschung; 1984; 34(10B):1386-91. PubMed ID: 6097262
[TBL] [Abstract][Full Text] [Related]
10. Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?
Sambhi MP; Gavras H; Robertson JI; Smith WM
West J Med; 1993 Mar; 158(3):286-94. PubMed ID: 8460511
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
Leary AC; MacDonald TM
Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
[TBL] [Abstract][Full Text] [Related]
12. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
13. Clinical potential: angiotensin converting enzyme inhibitor or angiotensin II antagonist?
McInnes GT
J Hypertens Suppl; 2001 Jun; 19(1):S61-7. PubMed ID: 11451217
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of inhibitors of the renin-angiotensin system.
Fouad-Tarazi FM
J Hypertens Suppl; 1994 Jul; 12(2):S25-9. PubMed ID: 7965262
[TBL] [Abstract][Full Text] [Related]
15. Anthology of the renin-angiotensin system: a one hundred reference approach to angiotensin II antagonists.
Ménard J
J Hypertens Suppl; 1993 Apr; 11(3):S3-11. PubMed ID: 8315517
[TBL] [Abstract][Full Text] [Related]
16. [Current aspects of tissue renin-angiotensin systems: atrial natriuretic peptide and prostaglandins in arterial hypertension].
Ferreira Montero IJ
Rev Esp Cardiol; 1990; 43 Suppl 1():24-33. PubMed ID: 2139975
[TBL] [Abstract][Full Text] [Related]
17. [The clinical pharmacology of angiotensin II antagonists].
Arabidze GG; Novikova LS
Farmakol Toksikol; 1990; 53(2):80-6. PubMed ID: 2369961
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease.
Mancia G; Dell'Oro R; Quarti-Trevano F; Scopelliti F; Grassi G
J Hypertens Suppl; 2006 Mar; 24(1):S51-6. PubMed ID: 16601574
[TBL] [Abstract][Full Text] [Related]
19. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
Burnier M
Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
